Entropy Technologies LP Reduces Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Entropy Technologies LP lessened its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 25.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 179,537 shares of the health services provider's stock after selling 61,883 shares during the quarter. Entropy Technologies LP owned approximately 0.10% of Teladoc Health worth $1,648,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of TDOC. Robeco Institutional Asset Management B.V. lifted its stake in Teladoc Health by 141.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider's stock worth $5,279,000 after purchasing an additional 337,305 shares during the last quarter. Janney Montgomery Scott LLC boosted its holdings in shares of Teladoc Health by 63.0% in the 3rd quarter. Janney Montgomery Scott LLC now owns 106,727 shares of the health services provider's stock valued at $980,000 after buying an additional 41,250 shares in the last quarter. Wealth Enhancement Advisory Services LLC purchased a new position in shares of Teladoc Health in the 3rd quarter valued at $111,000. Assenagon Asset Management S.A. acquired a new stake in Teladoc Health during the 3rd quarter worth $15,801,000. Finally, International Assets Investment Management LLC lifted its position in Teladoc Health by 693.0% in the third quarter. International Assets Investment Management LLC now owns 23,299 shares of the health services provider's stock valued at $214,000 after acquiring an additional 20,361 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently weighed in on TDOC shares. Deutsche Bank Aktiengesellschaft boosted their target price on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a report on Friday, November 1st. Piper Sandler decreased their price objective on Teladoc Health from $25.00 to $10.00 and set an "overweight" rating for the company in a report on Tuesday, August 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, August 1st. Barclays upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. Finally, TD Cowen dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $11.97.

Insider Activity at Teladoc Health

In other Teladoc Health news, COO Michael Willem Waters sold 4,218 shares of the firm's stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the sale, the chief operating officer now directly owns 78,309 shares of the company's stock, valued at approximately $560,692.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Mala Murthy sold 8,750 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $62,650.00. Following the completion of the sale, the chief financial officer now directly owns 85,767 shares in the company, valued at approximately $614,091.72. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Michael Willem Waters sold 4,218 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the transaction, the chief operating officer now directly owns 78,309 shares in the company, valued at $560,692.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,051 shares of company stock valued at $143,565. 0.95% of the stock is owned by insiders.

Teladoc Health Trading Down 0.2 %

Shares of TDOC stock traded down $0.02 during midday trading on Wednesday, reaching $9.68. 3,120,538 shares of the company traded hands, compared to its average volume of 5,502,432. The firm's 50 day simple moving average is $8.79 and its two-hundred day simple moving average is $9.44. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities research analysts anticipate that Teladoc Health, Inc. will post -1.19 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.